Replies to post #683279 on NorthWest Biotherapeutics Inc (NWBO)

[DJPele]

This also caught my attention.

I wonder in what capacity this data is being presented in.

[StonkMaster]

Reminds me of the quote from the Canadian doctor who stated in a video Q&A that Health Canada was "looking at it".

[StonkMaster]

Reply from Sumomof2:

What was shared by EBCI is this: “ The FDA needs to understand that not one treatment is viable for this disease as Glioblastoma (GBM) quickly becomes resistant to all treatment. Therefore, patients need to have multiple and varied treatment options so that when their tumor becomes resistant to a treatment, they are able to quickly pivot. In order to provide brain cancer patients multiple treatment options, increase patient Quality of Life, provide HOPE for this patient community, and encourage additional investment by the pharma/biotech companies into GBM research, the FDA needs to approve multiple treatment options for this patient population. Currently, there are a very limited number of treatment options FDA approved for this disease. EBCI and I are working very hard to expand access to treatment options and to improve Standard of Care for the brain tumor community.”

The status in the UK is different because they have the process to produce the vaccine so approval there might be sooner?